dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Stepien, Karolina M. |
dc.contributor.author | Kieć-Wilk, Beata |
dc.contributor.author | Lampe, Christina |
dc.contributor.author | Tangeraas, Trine |
dc.contributor.author | Cefalo, Graziella |
dc.contributor.author | Belmatoug, Nadia |
dc.contributor.author | del Toro Riera, Mireia |
dc.date.accessioned | 2022-03-14T13:33:18Z |
dc.date.available | 2022-03-14T13:33:18Z |
dc.date.issued | 2021-02 |
dc.identifier.citation | Stepien KM, Kieć-Wilk B, Lampe C, Tangeraas T, Cefalo G, Belmatoug N, et al. Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey. Front Med. 2021 Feb;8:652358. |
dc.identifier.issn | 2296-858X |
dc.identifier.uri | https://hdl.handle.net/11351/7172 |
dc.description | Malalties metabòliques hereditàries; Malaltia rara; Procés de transició |
dc.description.sponsorship | This work was generated within the European Reference Network for Rare Hereditary Metabolic Disorders (MetabERN), co-funded by the European Union within the framework of the Third Health Programme ERN-2016 - Framework Partnership Agreement 2017–2021, Project ID No. 739543. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Medicine;8 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Metabolisme - Trastorns - Aspectes genètics |
dc.subject | Diàtesi |
dc.subject.mesh | Metabolic Diseases |
dc.subject.mesh | /genetics |
dc.subject.mesh | Genetic Predisposition to Disease |
dc.title | Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fmed.2021.652358 |
dc.subject.decs | enfermedades metabólicas |
dc.subject.decs | /genética |
dc.subject.decs | predisposición genética a la enfermedad |
dc.relation.publishversion | https://doi.org/10.3389/fmed.2021.652358 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Stepien KM] Adult Inherited Metabolic Diseases, Salford Royal NHS Foundation Trust, Salford, United Kingdom. [Kieć-Wilk B] Department of Metabolic Diseases and Diabetes, Krakow University Hospital, Krakow, Poland. Department of Metabolic Diseases, Medical College, Jagiellonian University, Krakow, Poland. [Lampe C] Department of Child Neurology, Center for Rare Diseases Giessen (ZSEGI), Justus-Liebig University, Giessen, Germany. [Tangeraas T] Norwegian National Unit for Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway. [Cefalo G] Department of Maternal and Child Health, San Paolo Hospital, University of Milan, ASST Santi Paolo e Carlo, Milan, Italy. [Belmatoug N] Referral Center for Lysosomal Diseases, AP-HP Nord, Beaujon Hospital, Paris University, Clichy, France. [Del Toro M] Servei de Neurologia Pediàtrica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 33738294 |
dc.identifier.wos | 000629292700001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |